Oncology-Whitepaper-CRISPRTherapiesInOncology-VF (003)

Clinical Development of CRISPR-Based Therapies in Oncology

Novel Therapies, Unique Challenges

Great strides have been made within pre-clinical research and discovery efforts that inform and enable an oncology development program based on CRISPR/Cas9 gene editing techniques, but there remains much to consider when it comes to implementing an early phase clinical trial.

Read our white paper – the second in a series to learn more.

Your form has been successfully submitted! Click the button below to access.
Read more


Read the first paper in this CRISPR series:
CRISPR, Gene-Based Therapeutics, and Clinical Trials 


CRISPR and the Commercialization of Gene-Based Therapies